457 related articles for article (PubMed ID: 26468825)
1. Treatment of Osteonecrosis of the Jaw.
Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
[TBL] [Abstract][Full Text] [Related]
2. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
[TBL] [Abstract][Full Text] [Related]
3. Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw.
Chopra K; Malhan N
Am J Ther; 2020 Jun; 28(4):e469-e477. PubMed ID: 32618592
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw.
Zandi M; Dehghan A; Amini P; Doulati S; Rezaeian L
Clin Oral Investig; 2019 Nov; 23(11):3987-3993. PubMed ID: 30715621
[TBL] [Abstract][Full Text] [Related]
5. Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw.
Ohbayashi Y; Miyake M; Sawai F; Minami Y; Iwasaki A; Matsui Y
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):e31-7. PubMed ID: 23246226
[TBL] [Abstract][Full Text] [Related]
6. Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats.
Zandi M; Dehghan A; Mohammadi-Mofrad A; Amini P; Vahdatinia F
J Craniomaxillofac Surg; 2017 Feb; 45(2):275-280. PubMed ID: 28087282
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.
Lee JJ; Cheng SJ; Jeng JH; Chiang CP; Lau HP; Kok SH
Head Neck; 2011 Sep; 33(9):1366-71. PubMed ID: 20310042
[TBL] [Abstract][Full Text] [Related]
8. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
9. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
Ohbayashi Y; Iwasaki A; Nakai F; Mashiba T; Miyake M
Osteoporos Int; 2020 Mar; 31(3):577-585. PubMed ID: 31768589
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous Healing of Mandibular Noncontinuous Defect Caused by Medication-Related Osteonecrosis of the Jaw.
Yazan M; Atil F; Kocyigit ID; Tekin U; Tuz HH; Misirlioglu M
J Craniofac Surg; 2016 Jun; 27(4):e390-2. PubMed ID: 27244207
[TBL] [Abstract][Full Text] [Related]
11. Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study.
Jung J; Yoo HY; Kim GT; Lee JW; Lee YA; Kim DY; Kwon YD
J Bone Miner Res; 2017 Dec; 32(12):2445-2452. PubMed ID: 28815779
[TBL] [Abstract][Full Text] [Related]
12. Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: preliminary findings.
Kakehashi H; Ando T; Minamizato T; Nakatani Y; Kawasaki T; Ikeda H; Kuroshima S; Kawakami A; Asahina I
Int J Oral Maxillofac Surg; 2015 Dec; 44(12):1558-64. PubMed ID: 26304604
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-associated osteonecrosis of jaw reoccurrence after methotrexate therapy: a case report.
Alsalleeh F; Keippel J; Adams L; Bavitz B
J Endod; 2014 Sep; 40(9):1505-7. PubMed ID: 25146044
[TBL] [Abstract][Full Text] [Related]
14. Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series.
Yoshiga D; Yoshioka I; Habu M; Sasaguri M; Tominaga K
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):604-609. PubMed ID: 34996629
[TBL] [Abstract][Full Text] [Related]
15. Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW; Borromeo GL; Tsao C; Hardiman R; Hofman MS; Papatziamos Hjelle C; Siddique M; Cook GJR; Seymour JF; Ebeling PR
J Clin Oncol; 2020 Sep; 38(26):2971-2980. PubMed ID: 32614699
[TBL] [Abstract][Full Text] [Related]
16. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
[TBL] [Abstract][Full Text] [Related]
17. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Medication-Related Osteonecrosis of the Jaw Around the Dental Implant With a Once-Weekly Teriparatide: A Case Report and Literature Review.
Kim JY; Park JH; Jung HD; Jung YS
J Oral Implantol; 2019 Oct; 45(5):403-407. PubMed ID: 31429640
[TBL] [Abstract][Full Text] [Related]
19. Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws.
Yoshiga D; Yamashita Y; Nakamichi I; Tanaka T; Yamauchi K; Yamamoto N; Nogami S; Kaneuji T; Mitsugi S; Sakurai T; Kiyomiya H; Tominaga K; Morimoto Y; Takahashi T
Osteoporos Int; 2013 Aug; 24(8):2365-9. PubMed ID: 23371327
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]